SC 13G
SC 13G Filing
- Company
- BioLineRx Ltd.
- Filed
- January 7, 2015
- Accession Number
- 0000919574-15-000147
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →